根據FactSet最新調查 ，共19位分析師，對葛蘭素史克公司 (GSK-US)做出2025年EPS預估：中位數由4.12元上修至4.19元，其中最高估值4.42元，最低估值3.79元，預估目標價為38.40元。

Biopharmaceutical company GSK is growing its Massachusetts work force, announcing plans to move its vaccines research and development and infectious disease teams from suburban Maryland to ...

智通財經APP獲悉，今日（2月11日），中國國家藥監局（CDE）官網最新公示顯示，葛蘭素史克 (GSK.US)以生物製品2.2類申報的 抗IL-5單抗美泊利珠單抗注射液上市申請獲得受理。根據GSK官網及公開資料推測，本次美泊利珠單抗在中國申報上市的適應症可能爲慢性阻塞性肺疾病（COPD）。針對該適應症，美泊利珠單抗尚未在全球範圍內獲得批准。

許多縣市皆傳出流感疫苗已用罄災情，上周緊急再增購10萬劑公費流感疫苗，將於20日開始接種，不過，就有專家發現，這添購的10萬劑疫苗仍是舊款四價疫苗，認為如此的疫苗只具「打折」保護力，對此，衛福部則表示，今年秋冬流感季將採購最新的三價流感疫苗，10月起 ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...

Teva Pharmaceutical Industries Ltd. ADR-1.51% $18.8B ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

據福斯電視網最新披露，今年賽事廣告時段刷新歷史紀錄，30秒要價達800萬美元（約新台幣2.52億元），換算每秒成本高達28萬美元（約新台幣884萬元）。

After hours: 7:44:54 p.m. EST ...